Skip to content
MarketScale
‹ Back to IndustriesSciences

Investing in Water Quality: Florida Takes a Proactive Strategy for Sustainable Infrastructure

Florida is proactively addressing water quality by announcing a $1.5 billion investment, emphasizing the Everglades Restoration Project. This move is part of a broader strategy to improve infrastructure and ensure sustainable environmental practices as the state experiences population growth. Governor Ron DeSantis has positioned Florida as a leader in environmental sustainability efforts.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Dan Ferreira · Daniel FerreiraEnvironmental SciencesEverglades RestorationFlorida Everglades
Share

Key takeaways

01

Florida invests $1.5 billion in water quality, focusing on the Everglades.

02

The initiative aims to improve infrastructure for sustainable environmental practices.

03

Governor Ron DeSantis leads Florida's efforts in environmental sustainability.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

Amid a national conversation on infrastructure and environmental sustainability, Florida positions itself at the forefront with a significant financial commitment to investing in water quality. Governor Ron DeSantis’s recent announcement of a $1.5 billion investment, focusing heavily on the iconic Everglades Restoration Project, comes at a critical time. As Florida’s population continues to swell, the strain on water resources and wastewater systems grows, echoing a broader national urgency to upgrade aging infrastructures and ensure ecological and public health. The move aims to prevent scenarios like the 2022 Jackson, Mississippi water crisis, underscoring the high stakes of proactive environmental management.

What does this substantial investment mean for Florida’s future, and how will it impact its residents’ environment and quality of life? This pressing question has many Floridians and environmental scientists pondering.

Daniel Ferreira, the Assistant Chair and Associate Professor of Environmental Science at Kennesaw State University, offers a detailed analysis of the scope and implications of Florida’s water infrastructure strategy, highlighting the urgency of investing in water quality.

Here are the key takeaways from Professor Ferreira’s insights:

  • Preventative Investment: The funding is a crucial preventative measure to avoid disasters like those experienced in Jackson, Mississippi, where failed water systems led to severe public health crises
  • Long-term Sustainability: This investment caters to future water needs and infrastructure resilience, a strategic move as Florida’s population grows
  • Ecosystem Protection: By upgrading wastewater treatment facilities, Florida aims to prevent pollution in its waterways, crucial for maintaining healthy ecosystems and supporting biodiversity
  • Economic Implications: Beyond environmental benefits, robust water infrastructure can drive economic stability and growth, ensuring businesses and communities thrive
  • Public Health: Ensuring access to clean and safe water is fundamentally linked to public health, and this funding helps secure this right for all Floridians

Through this funding, Florida sets a national example for how states can and should invest in critical infrastructure, reflecting a broader commitment to environmental stewardship and public safety. The strategy of investing in water quality not only protects the environment but also enhances the quality of life for Florida’s residents.

Article by James Kent

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

DF
Dan Ferreira

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512